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Background
Human ferritin (HFn) is a promising nanoscale protein
cage platform for molecular/cellular imaging, and we
have developed engineered HFn nanoparticles as MRI
agents. Inflammation and angiogenesis contribute to
atherosclerosis, and RGD is a well-studied ligand of the
avb3 integrin expressed by activated macrophages and
angiogenic endothelial cells.
Purpose
To evaluate RGD-conjugated HFn-iron oxide nanoparti-
cles for enhanced in vivo MRI detection of murine caro-
tid atherosclerosis.
Methods
1) Mice
Fourteen FVB mice underwent left carotid ligation after
4 weeks of high-fat diet and diabetes induction by
streptozotocin.
2) RGD-conjugated HFn-iron oxide nanoparticles
Using the recombinant human heavy-chain ferritin pro-
tein cage, HFn was genetically engineered to display 24
copies of an RGD-4C peptide (CDCRGDCFC) on the
exterior surface of the protein cage. Magnetite (Fe3O4)
was encapsulated in interior cavities of RGD-conjugated
HFn (RGD
+ HFn) and non-targeted HFn (RGD
- HFn) at
loading factors of 5000Fe per cage, giving R2 values of
93 mM
-1s
-1 (magnetite diameter: 5-7nm, exterior dia-
meter: 12nm). The injected dose was adjusted to
25mgFe/kg.
3) MRI
Two weeks post ligation, mice were imaged on a whole-
body 3T MRI scanner (Signa HDx, GE Healthcare) with
a phased array mouse coil (RAPID MR International),
using a gradient echo sequence (TR/TE=100ms/10ms,
slice thickness=1.0mm, FOV=3cm, matrix=256x256,
FA=60, NEX=10). Mice were then injected with either
RGD
+ (n=7) or RGD
- (n=7) HFn nanoparticles, followed
by MRI at 24 and 48 hours post injection. The nanopar-
ticle accumulation was assessed by measuring the extent
of T2*-induced reduction in carotid lumen size (%
reduction of carotid lumen area).
4) Histology
Perl’s iron staining was performed to identify accumula-
tion of the nanoparticles in the carotid lesions.
Results
Both RGD
+ and RGD
- HFn nanoparticles caused a
reduction in lumen size of the ligated left carotid
arteries at 48 hrs due to T2* signal loss (p<0.001 vs. pre-
injection, Figures 1, 2), but the effect was significantly
greater with RGD
+ HFn (p=0.01 vs. RGD
- HFn). There
was no significant lumen reduction in the non-ligated
(control) right carotid arteries. Perl’s iron staining con-
firmed greater accumulation of RGD
+ HFn in the lesion
compared to RGD
- HFn, primarily in neointimal macro-
phages (Figure 3).
Conclusions
Human ferritin protein cage is a versatile nanoparticle
imaging platform for in vivo cellular/molecular MRI,
with enhanced atherosclerosis imaging through multiva-
lent RGD targeting.
1Stanford University School of Medicine, Stanford, CA, USA
Full list of author information is available at the end of the article
Kitagawa et al. Journal of Cardiovascular Magnetic Resonance 2011, 13(Suppl 1):P373
http://jcmr-online.com/content/13/S1/P373
© 2011 Kitagawa et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Author details
1Stanford University School of Medicine, Stanford, CA, USA.
2Montana State
University, Bozeman, MT, USA.
Published: 2 February 2011
doi:10.1186/1532-429X-13-S1-P373
Cite this article as: Kitagawa et al.: RGD targeting of human ferritin iron
oxide nanoparticles can enhance in vivo carotid MRI of experimental
atherosclerosis. Journal of Cardiovascular Magnetic Resonance 2011 13
(Suppl 1):P373.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Figure 1
Figure 2
Figure 3
Kitagawa et al. Journal of Cardiovascular Magnetic Resonance 2011, 13(Suppl 1):P373
http://jcmr-online.com/content/13/S1/P373
Page 2 of 2